BEIGENE: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 26 09:32 ET
BEIGENE: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 26 09:26 ET
BEIGENE: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 26 09:20 ET
BEIGENE: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 26 09:13 ET
BEIGENE: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 26 09:05 ET
BEIGENE: 2023 Responsible Business and Sustainability Report
Apr 25 06:11 ET
BEIGENE: 2023 ANNUAL REPORT
Apr 25 06:00 ET
BEIGENE: VOLUNTARY ANNOUNCEMENT - UPDATE REGARDING RECENT BUSINESS DEVELOPMENTS
Apr 23 07:32 ET
BEIGENE: DATE OF AUDIT COMMITTEE MEETING
Apr 22 06:16 ET
BEIGENE: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Apr 19 08:07 ET
BEIGENE: CONNECTED TRANSACTION - PROPOSED GRANTS OF RESTRICTED SHARE UNITS AND PERFORMANCE SHARE UNITS TO DIRECTORS
Apr 15 19:28 ET
BEIGENE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 8 06:21 ET
BEIGENE: GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS
Apr 5 04:30 ET
BEIGENE: Next Day Disclosure Return
Apr 1 19:02 ET
BEIGENE: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Mar 28 06:25 ET
BEIGENE: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-K
Mar 21 05:56 ET
BEIGENE: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Mar 21 05:50 ET
BEIGENE: APPOINTMENT OF MEMBER OF COMMERCIAL AND MEDICAL AFFAIRS ADVISORY COMMITTEE
Mar 21 05:45 ET
BEIGENE: DATE OF AUDIT COMMITTEE MEETING
Mar 15 06:02 ET
BEIGENE: INSIDE INFORMATION - BEIGENE RECEIVES FDA APPROVAL FOR TEVIMBRA (TISLELIZUMAB) FOR THE TREATMENT OF ADVANCED OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA AFTER PRIOR CHEMOTHERAPY
Mar 14 20:26 ET
No Data
No Data